Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 58

Sort by

Sort Order Select

Journal Articles

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

Alessandro Mattè, Angelo D'Alessandro, Mariarita Bertoldi, Richard Huot Pozzetto, Giovanni Bisello, Andrea Mattarei, Alberto Ongaro, Alice Passarini, Angela Siciliano, Roberta Russo, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi

Blood (2023) 142 (Supplement 1): 3850.

https://doi.org/10.1182/blood-2023-185681

Published: 2023

Journal Articles

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Enrica Federti, Domenico Mattoscio, Antonio Recchiuti, Alessandro Mattè, Maria Monti, Flora Cozzolino, Martina Ceci, Manuela Iezzi, Angela Siciliano, Veronica Riccardi, Alice Passarini, Carlo Brugnara, Lucia De Franceschi

Blood (2023) 142 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2023-185603

Published: 2023

Journal Articles

Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease

Alessandro Mattè, Antonio Recchiuti, Enrica Federti, Filippo Mazzi, Jacopo Ceolan, Annamaria Porreca, Marta Di Nicola, Sofia Menotti, Stefano Alivernini, Carlo Brugnara, Lucia De Franceschi

Blood (2022) 140 (Supplement 1): 5399–5400.

https://doi.org/10.1182/blood-2022-166240

Published: 2022

Journal Articles

Proteomic and Lipidomic Investigation of an Ex-Vivo Human Model of Sickle Cell Disease Erythropoiesis and Patient Erythrocytes Reveals the Abnormal Localization and Dysfunction of the Proteasome, Disrupted Antioxidant Defenses and Altered Lipid Profiles

Julien Delobel, Romain Hamelin, Viviane Praz, Hector Gallart-Ayala, Florence Armand, Manfredo Quadroni, Katia Balmas-Bourloud, Diego Chiappe, Carlo Brugnara, Julijana Ivanisevic, Raffaele Renella

Blood (2022) 140 (Supplement 1): 959–960.

https://doi.org/10.1182/blood-2022-160011

Published: 2022

Journal Articles

Altered Cellular Sedimentation during Apheresis Impacts Outcomes of Peripheral Blood Stem Cell Collection Efficiency in Patients with Sickle Cell Disease

David G. Justus, Erica B. Esrick, Matthew M. Heeney, Ellen Proeung, Carly Howard, Carlo Brugnara, David A. Williams, John P Manis

Blood (2022) 140 (Supplement 1): 5715–5716.

https://doi.org/10.1182/blood-2022-170450

Published: 2022

Journal Articles

Mitapivat Improves Transfusion Burden and Reduces Iron Overload in Thalassemic Mice

Alessandro Mattè, Penelope A. Kosinski, Enrica Federti, Lenny Dang, Angela Siciliano, Iana Iatcenko, Carlo Brugnara, Lucia De Franceschi

Blood (2021) 138 (Supplement 1): 2016.

https://doi.org/10.1182/blood-2021-153721

Published: 2021

Journal Articles

Less (Fe) is more (Hb) in SCA

Carlo Brugnara

Blood (2021) 137 (11): 1446–1447.

https://doi.org/10.1182/blood.2020010131

Published: 2021

Journal Articles

The Pyruvate Kinase Activator Mitapivat Ameliorates Anemia and Prevents Iron Overload in a Mouse Model of Hereditary Spherocytosis

Alessandro Mattè, BSc,PhD, Wilson Anand, Enrica Federti, PhD, Charles Kung, PhD, Penelope A. Kosinski, MS, Veronica Riccardi, Iana Iatcenko, Lenny Dang, PhD, Christophe Leboeuf, Anne Janin, PhD, Carlo Brugnara, MD, Mohandas Narla, DSc, Lucia De Franceschi, MD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-142232

Published: 2020

Journal Articles

Measuring Reticulocyte Hemoglobin Content As a Marker for Iron Deficiency and Response to Therapy Represents a Paradigm Shift in Care

Michael Auerbach, MD, Carlo Brugnara, MD, Steve Staffa, PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-134693

Published: 2020

Journal Articles

Resolution of sickle cell disease–associated inflammation and tissue damage with 17 R -resolvin D1

Alessandro Matte, Antonio Recchiuti, Enrica Federti, Bérengère Koehl, Thomas Mintz, Wassim El Nemer, Pierre-Louis Tharaux, Valentine Brousse, Immacolata Andolfo, Alessia Lamolinara, Olga Weinberg, Angela Siciliano, Paul C. Norris, Ian R. Riley, Achille Iolascon, Charles N. Serhan, Carlo Brugnara, Lucia De Franceschi

Blood (2019) 133 (3): 252–265.

https://doi.org/10.1182/blood-2018-07-865378

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Imatinib Protects Against Hypoxia/Reoxygenation Induced Lung and Kidney Injury in a Humanized Mouse Model for SCD

Alessandro Mattè, BSc,PhD, Enrica Federti, PhD, Antonio Rechiutti, Amtonella Panataleo, Roberta Russo, Francesco Turrini, MD PhD, Angela Siciliano, Pierre Louis Tharaux, MD PhD, Wassim El Nemer, PhD, Serge Cedrick, Anne Janin, PhD, Christophe Leboeuf, Wilson Babu, Achille Iolascon, MD PhD, Carlo Brugnara, MD, Lucia De Franceschi, MD

Blood (2018) 132 (Supplement 1): 725.

https://doi.org/10.1182/blood-2018-99-115832

Published: 2018

Journal Articles

Dietary Omega-3 Fatty Acid Supplementation Improves Sickle Cell Bone Disease By Affecting Osteoblastogenesis and Adipogenesis

Maria Teresa Valenti, PhD, Luca Dalle Carbonare, MD, Alessandro Mattè, BSc, PhD, Lorenzo Anez-Bustillos, Mark Puder, MD, Samuele Cheri, Michela Deiana, Enrica Federti, PhD, Serge Cedrick Toya Mbiandjeu, Angela Siciliano, Carlo Brugnara, MD, Lucia De Franceschi, MD

Blood (2018) 132 (Supplement 1): 2356.

https://doi.org/10.1182/blood-2018-99-115801

Published: 2018

Journal Articles

Optimized Beta-Globin Expression and Enucleation from Induced Red Blood Cells for In Vitro Modeling of Sickle Cell Disease

Tolulope O Rosanwo, BA, Melissa Kinney, PhD, Martha A Clark, PhD, Linda T Vo, PhD, R. Grant Rowe, MD PhD, Natasha M. Archer, MD, Matthew M Heeney, MD, Thorsten Schlaeger, PhD, Daniel E. Bauer, MD PhD, Mark D. Fleming, MD DPhil, Manoj T Duraisingh, PhD, Stuart H. Orkin, MD, Carlo Brugnara, MD, Trista North, PhD, George Q. Daley, MD PhD

Blood (2018) 132 (Supplement 1): 2359.

https://doi.org/10.1182/blood-2018-99-114136

Published: 2018

Journal Articles

Highly Efficient Therapeutic Gene Editing of BCL11A enhancer in Human Hematopoietic Stem Cells from ß-Hemoglobinopathy Patients for Fetal Hemoglobin Induction

Blood (2018) 132 (Supplement 1): 3482.

https://doi.org/10.1182/blood-2018-99-119365

Published: 2018

Journal Articles

Acoustic Levitation: A Novel Approach to Study the Physical Properties of Blood in Normal Subjects and in Patients with Sickle Cell Disease

Vahideh Ansari Hosseinzadeh, Carlo Brugnara, MD, R. Glynn Holt

Blood (2017) 130 (Supplement 1): 4776.

https://doi.org/10.1182/blood.V130.Suppl_1.4776.4776

Published: 2017

Journal Articles

A Selective ORAL GLYT1 Inhibitor, Improves Anemia and RED CELL Survival in a MOUSE MODEL of Beta-Thalassemia

Carlo Brugnara, MD, Anja Harmeier, Lucia De Franceschi, MD, Alessandro Matte, Michael Winter, Annette Koerner, Omar Khwaja, Thomas Singer, Elisabetta Beneduce, Enrica Federti, Angela Siciliano

Blood (2016) 128 (22): 1284.

https://doi.org/10.1182/blood.V128.22.1284.1284

Published: 2016

Journal Articles

Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis

Alessandro Mattè, PhD, Antonio Recchiuti, PhD, Charles Serhan, PhD, Angela Siciliano, Enrica Federti, Olga Weinberg, MD, Brian Kalish, MD, Carlo Brugnara, MD, Lucia De Franceschi, MD

Blood (2015) 126 (23): 966.

https://doi.org/10.1182/blood.V126.23.966.966

Published: 2015

Journal Articles

Dietary ω-3 Fatty Acid Supplementation As a Potential New Therapy for Vasculopathy in Sickle Cell Disease: Proof of Concept in a Transgenic Mouse Model

Brian T Kalish, MD, Alessandro Matte, PhD, Immacolata Andolfo, Achille Iolascon, Olga Weinberg, Angela Siciliano, Mrs, Enrica Federti, Mark Puder, MD PhD, Carlo Brugnara, MD, Lucia De Franceschi, MD

Blood (2014) 124 (21): 220.

https://doi.org/10.1182/blood.V124.21.220.220

Published: 2014

Journal Articles

Senicapoc, a Gardos Channel Inhibitor Developed to Treat Sickle Cell Disease, Exhibits Antimalarial Activity

Venee N. Tubman, MD MMSc, Pedro Mejia, PhD, Boris E. Shmukler, PhD, Seth L. Alper, MD PhD, James R. Mitchell, PhD, Carlo Brugnara, MD, Manoj T. Duraisingh, PhD

Blood (2014) 124 (21): 743.

https://doi.org/10.1182/blood.V124.21.743.743

Published: 2014

Journal Articles

Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1

Blood (2013) 121 (19): 3925–3935.

https://doi.org/10.1182/blood-2013-02-482489

Published: 2013

Includes: Supplemental data

NARROW

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease

Proteomic and Lipidomic Investigation of an Ex-Vivo Human Model of Sickle Cell Disease Erythropoiesis and Patient Erythrocytes Reveals the Abnormal Localization and Dysfunction of the Proteasome, Disrupted Antioxidant Defenses and Altered Lipid Profiles

Altered Cellular Sedimentation during Apheresis Impacts Outcomes of Peripheral Blood Stem Cell Collection Efficiency in Patients with Sickle Cell Disease

Mitapivat Improves Transfusion Burden and Reduces Iron Overload in Thalassemic Mice

Less (Fe) is more (Hb) in SCA

The Pyruvate Kinase Activator Mitapivat Ameliorates Anemia and Prevents Iron Overload in a Mouse Model of Hereditary Spherocytosis

Measuring Reticulocyte Hemoglobin Content As a Marker for Iron Deficiency and Response to Therapy Represents a Paradigm Shift in Care

Resolution of sickle cell disease–associated inflammation and tissue damage with 17 R -resolvin D1

Imatinib Protects Against Hypoxia/Reoxygenation Induced Lung and Kidney Injury in a Humanized Mouse Model for SCD

Dietary Omega-3 Fatty Acid Supplementation Improves Sickle Cell Bone Disease By Affecting Osteoblastogenesis and Adipogenesis

Optimized Beta-Globin Expression and Enucleation from Induced Red Blood Cells for In Vitro Modeling of Sickle Cell Disease

Highly Efficient Therapeutic Gene Editing of BCL11A enhancer in Human Hematopoietic Stem Cells from ß-Hemoglobinopathy Patients for Fetal Hemoglobin Induction

Acoustic Levitation: A Novel Approach to Study the Physical Properties of Blood in Normal Subjects and in Patients with Sickle Cell Disease

A Selective ORAL GLYT1 Inhibitor, Improves Anemia and RED CELL Survival in a MOUSE MODEL of Beta-Thalassemia

Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis

Dietary ω-3 Fatty Acid Supplementation As a Potential New Therapy for Vasculopathy in Sickle Cell Disease: Proof of Concept in a Transgenic Mouse Model

Senicapoc, a Gardos Channel Inhibitor Developed to Treat Sickle Cell Disease, Exhibits Antimalarial Activity

Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only